Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 6 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 10689392

    Anti-cancer compounds targeting ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  2. US 10674901

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  3. US 10676480

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  4. US 10653755

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted May 19, 2020 · Expires May 14, 2040

    granted

  5. US 10624959

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  6. US 10562938

    Theragnostic particles

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  7. US 10548979

    Light-activated compositions and methods using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  8. US 10518002

    Intraocular drug delivery and filter device and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  9. US 10519423

    High efficiency reprogramming of fibroblasts into cardiomyocytes

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  10. US 10520517

    Disease severity index for assessment of chronic liver disease

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  11. US 10517917

    Compositions and methods for preventing or treating pulmonary hypertension

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  12. US 10512687

    Compositions and methods for enhanced innate immunity

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  13. US 10512672

    Methods for the treatment of inflammatory joint disease

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  14. US 10508122

    Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted

  15. US 10488416

    Targeting breast cancer therapy based on stromal subtypes and CD146 composition

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  16. US 10478508

    Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  17. US 10456448

    PTD-SMAD7 therapeutics

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  18. US 10450384

    Compositions of alpha-1 antitrypsin fusion molecules

    The Regents of the University of Colorado · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  19. US 10428082

    Triazole derivatives of melampomagnolide B and methods of use thereof

    The Regents of the University of Colorado, a body · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  20. US 10428126

    Dermaseptin-type and piscidin-type antimicrobial peptides

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  21. US 10420813

    Competitive inhibitors of invariant chain expression and/or ectopic clip binding

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  22. US 10413620

    Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  23. US 10413603

    Compositions, methods and uses for improved human papilloma virus constructs

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  24. US 10406214

    Propionyl-CoA carboxylase compositions and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.